Erratum: Molecular disruption of RAD50 sensitizes human tumor cells to cisplatin-based chemotherapy (Journal of Clinical Investigation (2009) 119, 7, (1974-1985) doi:10.1172/JCI33816)

Waleed M. Abuzeid; Xiaoling Jiang; Guoli Shi; Hui Wang; David Paulson; Koji Araki; David Jungreis; James Carney; Bert W. O'Malley; Daqing Li

doi:10.1172/JCI66810

Erratum: Molecular disruption of RAD50 sensitizes human tumor cells to cisplatin-based chemotherapy (Journal of Clinical Investigation (2009) 119, 7, (1974-1985) doi:10.1172/JCI33816)

Waleed M. Abuzeid
, Xiaoling Jiang
, Guoli Shi
, Hui Wang
, David Paulson
, Koji Araki
, David Jungreis
, James Carney
, Bert W. O'Malley
, Daqing Li

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	4300
Number of pages	1
Journal	Journal of Clinical Investigation
Volume	122
Issue number	11
DOIs	https://doi.org/10.1172/JCI66810
State	Published - Nov 1 2012
Externally published	Yes

ASJC Scopus subject areas

General Medicine

Access to Document

10.1172/JCI66810

Cite this

Abuzeid, W. M., Jiang, X., Shi, G., Wang, H., Paulson, D., Araki, K., Jungreis, D., Carney, J., O'Malley, B. W., & Li, D. (2012). Erratum: Molecular disruption of RAD50 sensitizes human tumor cells to cisplatin-based chemotherapy (Journal of Clinical Investigation (2009) 119, 7, (1974-1985) doi:10.1172/JCI33816). Journal of Clinical Investigation, 122(11), 4300. https://doi.org/10.1172/JCI66810

Erratum: Molecular disruption of RAD50 sensitizes human tumor cells to cisplatin-based chemotherapy (Journal of Clinical Investigation (2009) 119, 7, (1974-1985) doi:10.1172/JCI33816). / Abuzeid, Waleed M.; Jiang, Xiaoling; Shi, Guoli et al.
In: Journal of Clinical Investigation, Vol. 122, No. 11, 01.11.2012, p. 4300.

Research output: Contribution to journal › Comment/debate › peer-review

Abuzeid, WM, Jiang, X, Shi, G, Wang, H, Paulson, D, Araki, K, Jungreis, D, Carney, J, O'Malley, BW & Li, D 2012, 'Erratum: Molecular disruption of RAD50 sensitizes human tumor cells to cisplatin-based chemotherapy (Journal of Clinical Investigation (2009) 119, 7, (1974-1985) doi:10.1172/JCI33816)', Journal of Clinical Investigation, vol. 122, no. 11, pp. 4300. https://doi.org/10.1172/JCI66810

@article{558aa4f638b74bf38bdd9710f3aa95c8,

title = "Erratum: Molecular disruption of RAD50 sensitizes human tumor cells to cisplatin-based chemotherapy (Journal of Clinical Investigation (2009) 119, 7, (1974-1985) doi:10.1172/JCI33816)",

author = "Abuzeid, \{Waleed M.\} and Xiaoling Jiang and Guoli Shi and Hui Wang and David Paulson and Koji Araki and David Jungreis and James Carney and O'Malley, \{Bert W.\} and Daqing Li",

year = "2012",

month = nov,

day = "1",

doi = "10.1172/JCI66810",

language = "English (US)",

volume = "122",

pages = "4300",

journal = "Journal of Clinical Investigation",

issn = "0021-9738",

publisher = "American Society for Clinical Investigation",

number = "11",

}

TY - JOUR

T1 - Erratum

T2 - Molecular disruption of RAD50 sensitizes human tumor cells to cisplatin-based chemotherapy (Journal of Clinical Investigation (2009) 119, 7, (1974-1985) doi:10.1172/JCI33816)

AU - Abuzeid, Waleed M.

AU - Jiang, Xiaoling

AU - Shi, Guoli

AU - Wang, Hui

AU - Paulson, David

AU - Araki, Koji

AU - Jungreis, David

AU - Carney, James

AU - O'Malley, Bert W.

AU - Li, Daqing

PY - 2012/11/1

Y1 - 2012/11/1

UR - https://www.scopus.com/pages/publications/84868618706

UR - https://www.scopus.com/pages/publications/84868618706#tab=citedBy

U2 - 10.1172/JCI66810

DO - 10.1172/JCI66810

M3 - Comment/debate

AN - SCOPUS:84868618706

SN - 0021-9738

VL - 122

SP - 4300

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

IS - 11

ER -

Erratum: Molecular disruption of RAD50 sensitizes human tumor cells to cisplatin-based chemotherapy (Journal of Clinical Investigation (2009) 119, 7, (1974-1985) doi:10.1172/JCI33816)

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this